balance equationreview2022-09-30
Difference 277000000 exceeds tolerance 144209000.000. Presentation or filing-vintage differences need review.
Revenue
$71.67B
Fiscal year ended 2026-06-30Net income
$1.66B
Fiscal year ended 2026-06-30Total assets
$157.08B
Fiscal year ended 2026-06-30Valuation, from the filing
| Public float | $88.00B | Market value of stock held by non-affiliates, as stated on the cover page for 2025-06-30 |
|---|---|---|
| Float per share | $333.93 | Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself. |
| Float / net income | 14.8× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / revenue | 0.3× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / equity | 2.1× | A lower bound on the multiple, because affiliate holdings are excluded. |
Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.
Valuation over time
14.8× earnings today, against a median of 16.0× across 3 years on record. In line with its own history.
| Float measured | Public float | Float / net income | |
|---|---|---|---|
| 2025-06-30 | $88.00B | 14.8× | |
| 2024-06-30 | $92.10B | 26.8× | |
| 2023-06-30 | $82.80B | 16.0× |
Each float is paired with the fiscal year the filing that stated it covers. Only years where the company reported positive net income appear, because a multiple against a loss is not a multiple.
How this compares in its industry
Percentile among the Hospital & Medical Service Plans filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.
| Measure | Reported | Percentile | |
|---|---|---|---|
| Current ratio | 0.85x | 11th | |
| Revenue YoY growth | 11.2% | 11th | |
| Effective tax rate | 19.2% | 80th | |
| Operating margin | 3.3% | 78th | |
| Net margin | 2.2% | 75th | |
| Long-term debt / equity | 0.74x | 62th | |
| Gross margin | 21.8% | 60th |
Cigna Group (CI) reported revenue of $71.67B and net income of $1.66B for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Cigna Group’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Hospital & Medical Service Plans.
Banks, brokers and insurers present a top line that is not comparable with an operating company’s revenue: it is reported net of interest expense, or as premiums earned, depending on the filer. The figures are the filer’s own and are traceable to the filing; the comparison across classes is what does not hold.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71.67B | $68.49B | $72.47B | $69.75B | $67.18B | $65.50B | $65.65B | $63.69B | $60.52B | $57.26B |
| Cost of revenue | $56.70B | $54.10B | $57.80B | $55.53B | $53.27B | $48.40B | $49.02B | $47.56B | $44.49B | $41.43B |
| Gross profit | $14.96B | $14.39B | $14.68B | $14.22B | $13.91B | $17.10B | $16.63B | $16.13B | $16.03B | $15.82B |
| Operating income | $2.68B | $2.36B | $2.34B | $2.58B | $2.31B | $1.97B | $2.17B | $2.58B | $2.41B | $2.26B |
| Net income | $1.66B | $1.65B | Unavailable | Unavailable | $1.53B | $1.32B | Unavailable | Unavailable | Unavailable | Unavailable |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 263.96M | shares 264.02M | Unavailable | shares 267.53M | shares 268.15M | shares 272.95M | Unavailable | shares 281.40M | shares 284.05M | shares 286.46M |
| Pretax income | $2.26B | $2.27B | $1.82B | $2.30B | $2.02B | $1.65B | $2.01B | $1.19B | $1.99B | $79.00M |
| Income tax expense | $382.00M | $409.00M | $543.00M | $322.00M | $389.00M | $239.00M | $473.00M | $367.00M | $360.00M | $291.00M |
| Diluted EPS | $6.29 | $6.26 | Unavailable | $6.98 | $5.71 | $4.85 | Unavailable | $2.63 | $5.45 | $-0.97 |
| Selling, general & administrative | $3.47B | $3.72B | $3.61B | $3.36B | $3.43B | $4.21B | $3.86B | $3.59B | $3.68B | $3.70B |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $6.30B | $7.04B | $7.68B | $6.02B | $4.33B | $8.33B | $7.55B | $5.89B | $6.79B | $8.44B |
| Total assets | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B | $157.64B | $155.45B | $153.12B |
| Current assets | $46.99B | $43.03B | $47.81B | $46.74B | $44.72B | $43.56B | $48.87B | $49.22B | $46.22B | $43.36B |
| Total liabilities | $114.17B | $110.82B | $116.04B | $115.90B | $111.22B | $110.24B | $114.64B | $115.34B | $113.92B | $111.77B |
| Current liabilities | $55.56B | $52.61B | $56.34B | $56.45B | $56.78B | $55.74B | $57.98B | $57.06B | $55.37B | $51.98B |
| Total equity incl. NCI | $42.91B | $42.44B | $41.87B | $42.01B | $40.43B | $40.41B | $41.24B | $42.30B | $41.53B | $41.35B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $0 | $0 | $0 | $0 |
| Inventory | $5.85B | $5.83B | $7.34B | $5.63B | $5.97B | $5.18B | $6.69B | $5.08B | $5.17B | $4.63B |
| Accounts receivable | $30.80B | $26.61B | $28.77B | $31.71B | $31.15B | $26.93B | $24.23B | $27.85B | $25.11B | $20.56B |
| Goodwill | $45.53B | $45.53B | $44.92B | $44.92B | $44.38B | $44.37B | $44.37B | $44.37B | $44.26B | $44.26B |
| Long-term debt | $29.09B | $29.37B | $30.87B | $30.95B | $26.48B | $26.46B | $28.94B | $30.23B | $30.18B | $31.05B |
| Accounts payable | $10.41B | $9.88B | $10.66B | $9.35B | $9.94B | $9.14B | $9.29B | $8.52B | $9.28B | $8.12B |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$421.00M | $1.13B | $6.15B | $3.42B | -$1.89B | $1.92B | $5.21B | $46.00M | $265.00M | $4.84B |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | -$503.00M | -$637.00M | -$420.00M | -$4.39B | -$797.00M | $1.20B | -$191.00M | -$776.00M | -$640.00M | -$495.00M |
| Financing cash flow | $207.00M | -$1.14B | -$4.07B | $2.66B | -$1.33B | -$3.68B | -$3.25B | $439.00M | -$2.31B | -$2.53B |
| Net change in cash | -$724.00M | -$656.00M | $1.66B | $1.68B | -$3.99B | -$555.00M | $1.75B | -$273.00M | -$2.69B | $1.81B |
| Stock-based compensation | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common dividends paid | $409.00M | $417.00M | $396.00M | $402.00M | $401.00M | $412.00M | $384.00M | $390.00M | $392.00M | $401.00M |
| Common share repurchases | $280.00M | $0 | $1.00B | $0 | $1.11B | $1.51B | $2.02B | $0 | $990.00M | $4.02B |
| Depreciation & amortization | $655.00M | $650.00M | $722.00M | $697.00M | $682.00M | $674.00M | $646.00M | $650.00M | $738.00M | $741.00M |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | 20.9% | 21.0% | 20.3% | 20.4% | 20.7% | 26.1% | 25.3% | 25.3% | 26.5% | 27.6% |
| Operating margin | 3.7% | 3.4% | 3.2% | 3.7% | 3.4% | 3.0% | 3.3% | 4.0% | 4.0% | 3.9% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Current ratio | 0.85x | 0.82x | 0.85x | 0.83x | 0.79x | 0.78x | 0.84x | 0.86x | 0.83x | 0.83x |
| Revenue YoY growth | 6.7% | 4.6% | 10.4% | 9.5% | 11.0% | 14.4% | 28.4% | 29.9% | 24.6% | 23.1% |
| Net margin | 2.3% | 2.4% | Unavailable | Unavailable | 2.3% | 2.0% | Unavailable | Unavailable | Unavailable | Unavailable |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | 0.68x | Unavailable | 0.74x | 0.74x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 16.9% | 18.0% | 29.9% | 14.0% | 19.2% | 14.5% | 23.5% | 30.8% | 18.1% | 368.4% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CI in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-07-30View SEC filing
10-Q · Filed 2026-04-30View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-10-30View SEC filing
10-Q · Filed 2025-07-31View SEC filing
10-Q · Filed 2025-05-02View SEC filing
Reconciliation checks needing review
1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.